Shuttle Pharmaceuticals Holdings, Inc. Common Stock SHPH
Key Stats
- Today's Range
- $3.89 – $4.21
- 50-Day Range
- $2.58 – $6.15
- 52-Week Range
- $2.58 – $55.90
- Volume
- 36K shs
- Average Volume
- 2.97 million shs
- Market Cap
- $2.55 million
- P/E Ratio
- 407.00
- Dividend Yield
- —
Valuation
- P/E Ratio
- 407.00
- Price / Book
- 0.76
- Price / Sales
- -0.27
Short Interest
- Short Interest
- 18.13%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $-9,516,824
- Net Income
- $-10,827,907
- Net Margin
- 113.78%
- Return on Equity
- -323.58%
- Debt-to-Equity
- —
About Shuttle Pharmaceuticals Holdings, Inc. Common Stock
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
Related Stocks
Compare head-to-head: SHPH vs LLY·SHPH vs JNJ·SHPH vs ABBV·SHPH vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.